We tested the idea that antibacterial therapies targeting shared exoproducts would be more evolutionarily robust than regular antibiotics. Using gallium, we extracellularly quenched the iron-scavenging molecules shared among Pseudomonas aeruginosa bacteria, inhibiting their growth and virulence i…